Clinical Trial Update: Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine [Phase 1]

View source ↗

Summary

The entry reports a Phase 1 clinical trial for a lyophilized Haemophilus influenzae type b conjugate vaccine by CanSino Biologics, currently listed as active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Lyophilized Haemophilus influenzae type b conjugate vaccine (Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Haemophilus Influenzae Type B Infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING